Short answer
Encompass Health Corp (EHC) filed an 8-K current report with the SEC on August 5, 2026 reporting Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 7.01 (Regulation FD Disclosure), Item 2.02 (Results of Operations and Financial Condition). Q2 and first-half 2026 financial results released for periods ended June 30, 2026.
Encompass Health Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 and first-half 2026 financial results released for periods ended June 30, 2026
- Exhibit 99.1 contains detailed results, giving investors the primary source for revenue, earnings and guidance data
- Same-store metrics include market consolidation and capacity expansions, limiting pure underlying hospital performance comparisons
Item 7.01 · Regulation FD Disclosure
- Supplemental information for the August 6, 2026 earnings call provides detailed operating, leverage, Adjusted EBITDA, and cash-flow metrics
- Adjusted EBITDA is central to credit-agreement covenants, including leverage and interest coverage requirements
- Covenant breach could accelerate repayment, restrict new debt, dividends, acquisitions, and asset dispositions
- Adjusted free cash flow excludes maintenance capital expenditures, noncontrolling-interest distributions, and selected items
- Investors should reconcile non-GAAP measures to GAAP results because excluded settlements, restructuring, hedging, and other items may recur
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $1,597.4M, up 9.6%, with Adjusted EBITDA $348.0M, up 9.2%, indicating sustained operating momentum
- Diluted continuing-operations EPS $1.55, up 10.7%, while discharges rose 5.6% to 68,895
- Full-year guidance increased: revenue $6,410M-$6,490M and Adjusted EBITDA $1,365M-$1,395M
- Repurchase authorization increased to $1B, with $145.8M repurchased year to date and approximately $188M remaining under the prior authorization
- Expansion continues: three hospitals and 139 beds opened year to date, with five additional hospitals planned before year-end
Item EX-99.2 · Exhibit EX-99.2
- Q2 revenue $1,597.4M, up 9.6%, with discharges up 5.6% and revenue per discharge up 3.9%
- Adjusted EBITDA $348.0M, up 9.2%, supporting adjusted EPS of $1.55, up 10.7%
- Full-year guidance raised: revenue $6,410M-$6,490M, adjusted EBITDA $1,365M-$1,395M, adjusted EPS $6.02-$6.25
- Adjusted free cash flow fell 4.8% to $177.0M in Q2 and 9.2% to $370.8M year-to-date
- Capacity expansion accelerated with 90 beds opened in Q2 and 389 new beds planned across 8 hospitals for 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Encompass Health Corp 8-K filings
Get the next EHC 8-K as it lands
Follow EHC for push alerts, or ask the research agent what this filing means.